Selected research
Market Structure
Global Medical Radioactive Microsphere Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Medical Radioactive Microsphere Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Medical Radioactive Microsphere Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Medical Radioactive Microsphere Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Medical Radioactive Microsphere Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Medical Radioactive Microsphere Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Medical Radioactive Microsphere Injection include YH Nu-Med, Grand Pharmaceutical Group Limited, New Radiomedicine Technology, Boston Scientific, Terumo, Sirtex Medical Limited, BWXT Medical, AtomVie and ABK Biomedical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Medical Radioactive Microsphere Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Medical Radioactive Microsphere Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Medical Radioactive Microsphere Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Medical Radioactive Microsphere Injection market size, projected growth trends, production technologies, key applications, and end-use industries.
Medical Radioactive Microsphere Injection Segment by Company
YH Nu-Med
Grand Pharmaceutical Group Limited
New Radiomedicine Technology
Boston Scientific
Terumo
Sirtex Medical Limited
BWXT Medical
AtomVie
ABK Biomedical
Medical Radioactive Microsphere Injection Segment by Type
Holmium 166 Microsphere Injection
Yttrium 90 Microsphere Injection
Others
Medical Radioactive Microsphere Injection Segment by Application
Cancer Treatment
Diagnosis
Others
Medical Radioactive Microsphere Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Radioactive Microsphere Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Radioactive Microsphere Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Radioactive Microsphere Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Medical Radioactive Microsphere Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Medical Radioactive Microsphere Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Medical Radioactive Microsphere Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Medical Radioactive Microsphere Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Holmium 166 Microsphere Injection
- Yttrium 90 Microsphere Injection
- Others
Applications
- Cancer Treatment
- Diagnosis
- Others
Companies covered
- YH Nu-Med
- Grand Pharmaceutical Group Limited
- New Radiomedicine Technology
- Boston Scientific
- Terumo
- Sirtex Medical Limited
- BWXT Medical
- AtomVie
- ABK Biomedical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Medical Radioactive Microsphere Injection Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Medical Radioactive Microsphere Injection Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Medical Radioactive Microsphere Injection Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Medical Radioactive Microsphere Injection Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Medical Radioactive Microsphere Injection Market Dynamics
- 2.1 Medical Radioactive Microsphere Injection Industry Trends
- 2.2 Medical Radioactive Microsphere Injection Industry Drivers
- 2.3 Medical Radioactive Microsphere Injection Industry Opportunities and Challenges
- 2.4 Medical Radioactive Microsphere Injection Industry Restraints
3 Medical Radioactive Microsphere Injection Market by Manufacturers
- 3.1 Global Medical Radioactive Microsphere Injection Revenue by Manufacturers (2021-2026)
- 3.2 Global Medical Radioactive Microsphere Injection Sales by Manufacturers (2021-2026)
- 3.3 Global Medical Radioactive Microsphere Injection Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Medical Radioactive Microsphere Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Medical Radioactive Microsphere Injection Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Medical Radioactive Microsphere Injection Manufacturers, Product Type & Application
- 3.7 Global Medical Radioactive Microsphere Injection Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Medical Radioactive Microsphere Injection Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Medical Radioactive Microsphere Injection Players Market Share by Revenue in 2025
- 3.8.3 2025 Medical Radioactive Microsphere Injection Tier 1, Tier 2, and Tier 3
4 Medical Radioactive Microsphere Injection Market by Type
- 4.1 Medical Radioactive Microsphere Injection Type Introduction
- 4.1.1 Holmium 166 Microsphere Injection
- 4.1.2 Yttrium 90 Microsphere Injection
- 4.1.3 Others
- 4.2 Global Medical Radioactive Microsphere Injection Sales by Type
- 4.2.1 Global Medical Radioactive Microsphere Injection Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Medical Radioactive Microsphere Injection Sales by Type (2021-2032)
- 4.2.3 Global Medical Radioactive Microsphere Injection Sales Market Share by Type (2021-2032)
- 4.3 Global Medical Radioactive Microsphere Injection Revenue by Type
- 4.3.1 Global Medical Radioactive Microsphere Injection Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Medical Radioactive Microsphere Injection Revenue by Type (2021-2032)
- 4.3.3 Global Medical Radioactive Microsphere Injection Revenue Market Share by Type (2021-2032)
5 Medical Radioactive Microsphere Injection Market by Application
- 5.1 Medical Radioactive Microsphere Injection Application Introduction
- 5.1.1 Cancer Treatment
- 5.1.2 Diagnosis
- 5.1.3 Others
- 5.2 Global Medical Radioactive Microsphere Injection Sales by Application
- 5.2.1 Global Medical Radioactive Microsphere Injection Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Medical Radioactive Microsphere Injection Sales by Application (2021-2032)
- 5.2.3 Global Medical Radioactive Microsphere Injection Sales Market Share by Application (2021-2032)
- 5.3 Global Medical Radioactive Microsphere Injection Revenue by Application
- 5.3.1 Global Medical Radioactive Microsphere Injection Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Medical Radioactive Microsphere Injection Revenue by Application (2021-2032)
- 5.3.3 Global Medical Radioactive Microsphere Injection Revenue Market Share by Application (2021-2032)
6 Global Medical Radioactive Microsphere Injection Sales by Region
- 6.1 Global Medical Radioactive Microsphere Injection Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Medical Radioactive Microsphere Injection Sales by Region (2021-2032)
- 6.2.1 Global Medical Radioactive Microsphere Injection Sales by Region (2021-2026)
- 6.2.2 Global Medical Radioactive Microsphere Injection Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Medical Radioactive Microsphere Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Medical Radioactive Microsphere Injection Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Medical Radioactive Microsphere Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Medical Radioactive Microsphere Injection Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Medical Radioactive Microsphere Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Medical Radioactive Microsphere Injection Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Medical Radioactive Microsphere Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Medical Radioactive Microsphere Injection Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Medical Radioactive Microsphere Injection Revenue by Region
- 7.1 Global Medical Radioactive Microsphere Injection Revenue by Region
- 7.1.1 Global Medical Radioactive Microsphere Injection Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Medical Radioactive Microsphere Injection Revenue by Region (2021-2026)
- 7.1.3 Global Medical Radioactive Microsphere Injection Revenue by Region (2027-2032)
- 7.1.4 Global Medical Radioactive Microsphere Injection Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Medical Radioactive Microsphere Injection Revenue (2021-2032)
- 7.2.2 North America Medical Radioactive Microsphere Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Medical Radioactive Microsphere Injection Revenue (2021-2032)
- 7.3.2 Europe Medical Radioactive Microsphere Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Medical Radioactive Microsphere Injection Revenue (2021-2032)
- 7.4.2 Asia-Pacific Medical Radioactive Microsphere Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Medical Radioactive Microsphere Injection Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Medical Radioactive Microsphere Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 YH Nu-Med
- 8.1.1 YH Nu-Med Company Information
- 8.1.2 YH Nu-Med Business Overview
- 8.1.3 YH Nu-Med Medical Radioactive Microsphere Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 YH Nu-Med Medical Radioactive Microsphere Injection Product Portfolio
- 8.1.5 YH Nu-Med Recent Developments
- 8.2 Grand Pharmaceutical Group Limited
- 8.2.1 Grand Pharmaceutical Group Limited Company Information
- 8.2.2 Grand Pharmaceutical Group Limited Business Overview
- 8.2.3 Grand Pharmaceutical Group Limited Medical Radioactive Microsphere Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Grand Pharmaceutical Group Limited Medical Radioactive Microsphere Injection Product Portfolio
- 8.2.5 Grand Pharmaceutical Group Limited Recent Developments
- 8.3 New Radiomedicine Technology
- 8.3.1 New Radiomedicine Technology Company Information
- 8.3.2 New Radiomedicine Technology Business Overview
- 8.3.3 New Radiomedicine Technology Medical Radioactive Microsphere Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 New Radiomedicine Technology Medical Radioactive Microsphere Injection Product Portfolio
- 8.3.5 New Radiomedicine Technology Recent Developments
- 8.4 Boston Scientific
- 8.4.1 Boston Scientific Company Information
- 8.4.2 Boston Scientific Business Overview
- 8.4.3 Boston Scientific Medical Radioactive Microsphere Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Boston Scientific Medical Radioactive Microsphere Injection Product Portfolio
- 8.4.5 Boston Scientific Recent Developments
- 8.5 Terumo
- 8.5.1 Terumo Company Information
- 8.5.2 Terumo Business Overview
- 8.5.3 Terumo Medical Radioactive Microsphere Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Terumo Medical Radioactive Microsphere Injection Product Portfolio
- 8.5.5 Terumo Recent Developments
- 8.6 Sirtex Medical Limited
- 8.6.1 Sirtex Medical Limited Company Information
- 8.6.2 Sirtex Medical Limited Business Overview
- 8.6.3 Sirtex Medical Limited Medical Radioactive Microsphere Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Sirtex Medical Limited Medical Radioactive Microsphere Injection Product Portfolio
- 8.6.5 Sirtex Medical Limited Recent Developments
- 8.7 BWXT Medical
- 8.7.1 BWXT Medical Company Information
- 8.7.2 BWXT Medical Business Overview
- 8.7.3 BWXT Medical Medical Radioactive Microsphere Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 BWXT Medical Medical Radioactive Microsphere Injection Product Portfolio
- 8.7.5 BWXT Medical Recent Developments
- 8.8 AtomVie
- 8.8.1 AtomVie Company Information
- 8.8.2 AtomVie Business Overview
- 8.8.3 AtomVie Medical Radioactive Microsphere Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 AtomVie Medical Radioactive Microsphere Injection Product Portfolio
- 8.8.5 AtomVie Recent Developments
- 8.9 ABK Biomedical
- 8.9.1 ABK Biomedical Company Information
- 8.9.2 ABK Biomedical Business Overview
- 8.9.3 ABK Biomedical Medical Radioactive Microsphere Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 ABK Biomedical Medical Radioactive Microsphere Injection Product Portfolio
- 8.9.5 ABK Biomedical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Medical Radioactive Microsphere Injection Value Chain Analysis
- 9.1.1 Medical Radioactive Microsphere Injection Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Medical Radioactive Microsphere Injection Production Mode & Process
- 9.2 Medical Radioactive Microsphere Injection Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Medical Radioactive Microsphere Injection Distributors
- 9.2.3 Medical Radioactive Microsphere Injection Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst